NOVONIX Limited American Depository Shares (NVX)

FairStock Score: 44/100 — MIXED

Key Financials

Current Price$2.09
Market Cap$164M
P/E Ratio-0.37
ROE-65.64%
Dividend Yield—%
SectorIndustrials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At the close on 2026-10-13, Mr. Market asked $2.34 for NOVONIX, a $163.8 million battery materials and testing company with 192 employees. I begin with Graham's question: what is the business worth, and is the price offering a margin of safety? The supplied figures are not comforting. The FairStock-calculated P/E is negative at -0.42, return on equity is -65.64%, and return on capital employed is -12.90%. A Piotroski F-Score of 1/9 and an Altman Z-Score of -1.09 point to poor financial momentum and meaningful distress risk. The balance sheet is levered, with debt-to-equity of 0.58, and there is no dividend to wait for. The one apparent attraction is P/B of 0.37: the market values the equity at a steep discount to book value. For a capital-intensive battery materials company, book value may not be a reliable floor, especially when returns are negative and cash burn is likely. Competitive advantage? I see none established in these figures. NOVONIX operates in battery materials, technology, and graphite exploration, areas with large capital needs and price competition. Revenue and profit growth are not available in the data, and the Lynch category is none because only zero years of filed results are available and three are needed. That thin history limits confidence. Beta of 0.85 suggests less volatility than the market, but beta does not pay bills. A 52-week range of $0.37 to $4.60 shows how wildly the market has repriced the story. My conclusion: this is a speculative turnaround or asset story, not a proven Buffett-style compounder. The price looks statistically cheap on book, but the quality and health metrics argue caution. I would need evidence of positive cash generation, stable filings, and better returns before treating the discount as a true margin of safety.

In plain English: NOVONIX makes battery materials, testing equipment, and related research services for the battery industry. The business currently loses money, shows weak profitability and some balance-sheet warning signs, and has very little reported financial history. At $2.34, the shares look cheap compared with its accounting net assets, but that discount may reflect real operating risk rather than a safe bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer